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Abstract
Background: Upon repeated or chronic antigen stimulation, activated T cells undergo a T cell
receptor (TCR)-triggered propriocidal cell death important for governing the intensity of immune
responses. This is thought to be chiefly mediated by an extrinsic signal through the Fas-FasL
pathway. However, we observed that TCR restimulation still potently induced apoptosis when this
interaction was blocked, or genetically impaired in T cells derived from autoimmune
lymphoproliferative syndrome (ALPS) patients, prompting us to examine Fas-independent, intrinsic
signals.
Results: Upon TCR restimulation, we specifically noted a marked increase in the expression of
BIM, a pro-apoptotic Bcl-2 family protein known to mediate lymphocyte apoptosis induced by
cytokine withdrawal. In fact, T cells from an ALPS type IV patient in which BIM expression is
suppressed were more resistant to restimulation-induced death. Strikingly, knockdown of BIM
expression rescued normal T cells from TCR-induced death to as great an extent as Fas disruption.
Conclusion: Our data implicates BIM as a critical mediator of apoptosis induced by restimulation
as well as growth cytokine withdrawal. These findings suggest an important role for BIM in
eliminating activated T cells even when IL-2 is abundant, working in conjunction with Fas to
eliminate chronically stimulated T cells and maintain immune homeostasis.
Reviewers: This article was reviewed by Dr. Wendy Davidson (nominated by Dr. David Scott),
Dr. Mark Williams (nominated by Dr. Neil Greenspan), and Dr. Laurence C. Eisenlohr.
Background
Proper homeostasis is achieved during  an immune
response by controlling the appropriate size and activity
of the effector T cell pool to maximize immunity and min-
imize immunopathology. After  an immune response,
homeostasis depends on the efficient contraction of the
expanded T effector pool. Both processes require the selec-
tive death of effector T cells [1-5]. When resting T cells
become activated and proliferate under the influence of
growth cytokines, they display heightened sensitivity to
apoptosis [3,5,6]. The mechanisms by which apoptosis is
provoked have been thought to differ depending on the
level of antigen in the T cell milieu. In one simple schema,
T cell apoptosis proceeds through either an "intrinsic"
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(Bcl-2 superfamily/mitochondrial-dependent) program
when antigen levels are low, or an "extrinsic" (Fas/CD95/
APO-1/death receptor-mediated) pathway under condi-
tions of high or repeated antigen stimulation [1,4,5,7]. In
the first case, antigen clearance at the conclusion of an
immune response results in diminished growth and sur-
vival cytokines (such as interleukin-2 (IL-2)), thus activat-
ing the mitochondrial death program. Cytokine
withdrawal apoptosis (CWA) dramatically reduces the
expanded T effector population to re-establish homeosta-
sis, but permits a small population to persist as memory T
cells. CWA is principally regulated by the pro- and anti-
apoptotic members of the Bcl-2 family. In particular, the
pro-apoptotic "BH3-only" proteins Bim and Puma have
been implicated in CWA, as revealed by expanded mem-
ory T cells in knockout mice [8-10]. These "BH3 only"
members of the Bcl-2 superfamily cause caspase activation
and apoptosis by binding pro-survival congeners and
releasing the proapoptotic proteins Bax and Bak [11].
Moreover, we recently discovered that a gain-of-function
mutation in N-RAS, which suppresses Bim expression via
constitutive extracellular signal-related kinase (ERK) acti-
vation, could cause a novel form of ALPS in humans [12].
Indeed, Bim expression is tightly controlled by several
transcriptional and post-translational mechanisms that
underscore its role in central and peripheral T cell toler-
ance [13].
On the other hand, the extrinsic apoptosis pathway
involves restimulation of activated T cells with high doses
of antigen during the immune response; a pathway often
referred to as "activation-induced cell death (AICD)"
[1,7,14]. However, it is important not to obfuscate the
critical functional distinction between "activation" – the
process entrained to the antigen receptor that causes rest-
ing cells to cycle, expand, and acquire effector function –
and the death mechanism induced by TCR restimulation
of those effector T cells that counterposes their expansion.
So the term "TCR restimulation" or "TCR-induced" apop-
tosis will be used herein. The key immunoregulatory con-
sideration is why restimulation by same antigen that
produced the immune response, can kill the participating
T cells in a highly specific way. At first glance, this event
would seem to debilitate the immune response since the
antigen, and presumably its pathogenic source, are still
present. However, it is best understood as a negative feed-
back mechanism that constrains effector T cell prolifera-
tion to avoid immunopathology, previously termed
"propriocidal" regulation [3,4,6]. Propriocidal or TCR-
induced death increases proportionately with high or per-
sistent levels of antigen in IL-2. TCR-induced death has
hitherto been primarily equated with the Fas death recep-
tor. Indeed, the upregulation of Fas ligand (FasL) on the
surface of restimulated T cells engages Fas on effector T
cells in cis ("suicide") or in trans ("fratricide") leading to
apoptosis [15-18]. Moreover, debilitating mutations in
Fas or FasL result in defective lymphocyte homeostasis
and autoimmunity first characterized in mice (lpr and gld,
respectively) and later in humans with ALPS type Ia or Ib
[19,20].
The Bim vs. Fas paradigm recently restated for intrinsic vs.
extrinsic T cell apoptosis is appealing in its simplicity but
illusory. For instance, other BH3-only proteins such as
PUMA are likely instrumental in CWA [9,10]. Also, the
evidence suggests that Fas may not be the sole mediator of
TCR-induced death and that TNF or nonapoptotic path-
ways may be involved [21,22]. Data from conditional
knockout mice in which Fas is ablated or blocked in dis-
tinct hematopoietic compartments indicate that Fas-
mediated apoptosis may also counter autoimmunity by
ensuring the removal of antigen presenting cells, includ-
ing B cells and dendritic cells rather than T cells [23,24].
Although autoreactive T cells accumulate in T cell-specific
Fas knockout mice, surprisingly, loss of Fas confers no
selective survival advantage for T cells exposed to repeated
antigen challenge [24]. Also, Fas engagement can intersect
with the intrinsic pathway through a caspase-8 activating
cleavage of Bid – a Bcl-2 superfamily member that can
trigger mitochondrial apoptosis. Based on these insights,
we asked whether death effector pathways other than Fas,
including intrinsic signals routed through mitochondrial
activation, were important for TCR-induced death of
human T cells.
In re-examining human T cells in which FAS signaling is
blocked or genetically impaired, we found that TCR-
induced apoptosis can proceed through rapid induction
of BIM expression in the absence of FAS signals, which
contributes to mitochondrial permeabilization and cell
death in the presence of IL-2. Knockdown of BIM expres-
sion partially rescued cells from TCR-induced death, par-
ticularly for CD8+ human T cells. Moreover, we show that
TCR-induced apoptosis is normal for ALPS Ia patients dis-
playing elevated BIM expression, but impaired in an ALPS
type IV patient in which BIM expression is repressed. Col-
lectively, these data indicate that FAS and BIM can coop-
erate as independent effector molecules in TCR-induced
apoptosis. Our results show BIM plays a key role in T cell
contraction even when cytokines are abundant, indicating
that FAS- and BIM-mediated T cell apoptosis are not
mutually exclusive pathways as recently reinforced in the
literature [7].
Methods
Cells and Treatments
Patients were enrolled and blood samples were obtained
with informed consent under protocols approved by the
National Institutes of Health (NIH). Peripheral blood
lymphocytes (PBL) from normal donors were isolated byBiology Direct 2008, 3:34 http://www.biology-direct.com/content/3/1/34
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Ficoll density gradient centrifugation, and T cells were
activated by either 5 μg/ml ConA or 1 μg/ml OKT3 mAb
(Ortho Biotech, Raritan, NJ) plus 25 U/ml rhIL-2 (Pepro-
tech, Rocky Hill, NJ), washed 3× in PBS, then cultured in
100 U/ml rhIL-2 for at least 7 days before apoptosis assays
were performed. Activated T cell subsets were separated
using CD4 or CD8 Microbeads and MACS magnetic bead
cell separation (Miltenyi Biotec, Auburn, CA). In some
experiments, inhibitors to caspase 8 (IETD-fmk) or cas-
pase 9 (LEHD) (BioVision, Palo Alto, CA) were added at
20 μM. Caspase 9 enzymatic activity was measured using
a Caspase 9 Colorimetric Assay Kit (BioVision) according
to the manufacturer's instructions.
Flow Cytometry
Apoptosis assays were performed as previously described
[12]. Briefly, activated T cells were resuspended in fresh
media + IL-2 and stimulated for 24 h with soluble OKT3
mAb, agonistic anti-Fas mAb APO1.3 (Alexis, San Diego,
CA) plus 200 ng/ml Protein A, or 2 μM staurosporine. In
some experiments, 1 μg/ml of an antagonistic Fas block-
ing Ab (clone SM1/23, Alexis) was added to cells 30 min-
utes prior to OKT3 restimulation. The level of apoptosis
was determined by staining with 1 μg/ml propidium
iodide and flow cytometry analysis using constant time
acquisition as previously described. Mitochondrial per-
meability was measured by staining with 40 nM 3,3'-
dihexyloxacarbocyanine iodide (DiOC6) (EMD Bio-
sciences, San Diego, CA) for 15 min at 37°C before flow
cytometry analysis. For surface staining, cells were stained
with 5 μg anti-CD4-fluorescin isothiocyanate (FITC), anti-
CD8-phycoerythrin (PE), or anti-CD95-PE (BD Bio-
sciences).
Electron Microscopy
Treated cells (5 × 106) were pelleted and overlaid with 2%
glutaraldehyde in 0.1 M cacodylate buffer fixative for 2 h
at room temperature (RT). Sample preparation and elec-
tron microscopy was performed at the Image Analysis
Laboratory of the National Cancer Institute (Frederick,
MD).
Mircoarray Analysis
RNA was isolated from two normal donor activated T cells
at 0 or 6 h after OKT3 restimulation using Trizol (Invitro-
gen) and RNeasy mini-columns (Qiagen, Valencia, CA).
Purified RNA was amplified using the Ovation Aminoallyl
Amplification System (NuGEN, San Carlos, CA), labeled
with Cy5 using the Cy5 Reactive Dye Pack (GE Healthcare,
Piscataway, NJ), and cleaned up using Vivaspin columns
(VivaScience AG, Hanover, Germany). Amplified RNA (2
μg) was hybridized to Hsbb 23K human spotted arrays
(NIAID Mircoarray Research Facility) versus Cy3-labeled
reference RNA pooled from six normal donor cycling T
cells. Data was analyzed using GenePix and mAdb soft-
ware.
Immunoblotting
Cells were lysed in 1% NP-40 lysis buffer for 15 min on
ice, then cleared by centrifugation. Protein concentration
was determined by BCA assay (Pierce, Rockford, IL), and
20–30 μg total protein was separated by SDS-PAGE. Blots
were probed with the following antibodies (Abs): anti-
BIM (Stressgen, Ann Arbor, MI); anti-BAX, anti-cyto-
chrome c (clone 7H8.2C12), anti-BCL-xL, anti-BCL-2,
anti-MCL-1 (BD Pharmingen); anti-PUMA (Alexis); anti-
β-actin (clone AC-15, Sigma). Bound Abs were detected
using appropriate horseradish peroxidase-conjugated sec-
ondary Abs (Southern Biotech, Birmingham, AL) and ECL
(Pierce).
siRNA Transfections
Activated human PBL were transfected with 200 pmol of
either specific small interfering RNA oligoribonucleotides
(siRNA) or a non-specific (NS) control oligo (Invitrogen,
Carlsbad, CA) using the Amaxa Nucleofection system
(Amaxa, Koln, Germany). Assessment of knockdown effi-
ciency and all subsequent assays were performed 4 days
(human) post-transfection. siRNA sequences are available
from Invitrogen (Stealth Select).
Results and discussion
TCR restimulation induces apoptosis signals independent 
of FAS
To examine TCR-induced death in human T cells, acti-
vated peripheral blood lymphocytes (PBL) from normal
donors were restimulated with the anti-CD3 mAb OKT3
after cycling in IL-2 for 7–14 days. The majority of these
cells are CD4+ and CD8+ T cells, with the latter generally
more abundant in culture. Data was obtained for numer-
ous human donors. We found that apoptosis was readily
induced in restimulated T cells, marked by chromatin
condensation and shrinkage (Figure 1A). This was fol-
lowed by loss of membrane integrity due to secondary
necrosis. Apoptosis was verified by PI exclusion; however,
we noted that blocking FAS with an antagonistic Ab (SM1/
23) provided only partial protection against TCR-induced
death (Figure 1B). Flow cytometric analysis of restimu-
lated T cells also confirmed cell shrinkage and loss of
mitochondrial membrane potential, as indicated by
decreased DiOC6 staining following 12 h of OKT3 treat-
ment, signifying apoptosis (Figure 1C). Again, blocking
Fas with an antagonistic Ab (SM1/23) only partially res-
cued this drop in mitochondrial membrane potential and
cell viability. Remarkably, T cells from an ALPS Ia patient
with a FAS death domain mutation also showed only a
modest loss of mitochondrial membrane potential and
viability (Figure 1C), suggesting a mitochondria-depend-
ent apoptotic signal could proceed despite compromisedBiology Direct 2008, 3:34 http://www.biology-direct.com/content/3/1/34
Page 4 of 17
(page number not for citation purposes)
FAS function. Similarly, cytochrome c released from mito-
chondria in response to OKT3 restimulation was only
modestly decreased by FAS blockade (Figure 1D). We also
tested caspase 9 activation, which occurs downstream of
cytochrome c release and "apoptosome" formation. As
expected, caspase 9 activation was only partially reduced
in restimulated cells in the presence of FAS blocking Ab,
but completely abrogated in the presence of the caspase 9
specific inhibitor LEHD-fmk (Figure 1E). In contrast, the
SM1/23 Ab effectively blocked APO1.3 anti-Fas induced
apoptosis, indicating that the cells were competent for
FAS-mediated death (Additional File 1). Taken together,
our data confirms that TCR-induced death relies in part on
intrinsic mitochondrial signals triggered independently of
FAS-FASL interactions.
Role for BIM induction in TCR-induced death
Initial studies of AICD indicated that de novo transcription
was required for the execution of apoptosis in response to
T cell restimulation[17]. Since our data pointed toward a
TCR re-stimulation signals mitochondrial-dependent apoptosis independent of FAS Figure 1
TCR re-stimulation signals mitochondrial-dependent apoptosis independent of FAS. (A) Electron micrographs 
(upper panels, 2500× magnification or lower panels, 10000×) of activated human PBL either not restimulated (NRS) or restim-
ulated with OKT3 mAb for 18 h. Arrows indicate apoptotic cells. (B) Activated human T cells were untreated (NRS) or restim-
ulated with OKT3 for 24 h in the presence of FAS blocking Ab (SM1/23) or isotype control Ab. Cells were stained with PI and 
analyzed by flow cytometry; gates indicate % viable cells. (C) Activated human T cells from a normal donor or ALPS 1a patient 
were untreated (NRS) or restimulated with OKT3 for 12 h in the presence of FAS blocking Ab (SM1/23) or isotype control 
Ab. Cells were stained with DiOC6 and analyzed by flow cytometry (right panels). Viable gates are shown at left, and the per-
centage of DiOC6 low cells are indicated in the histograms on the right. (D) Cytosolic extracts from activated human PBL 
were immunoblotted for the presence of cytochrome c following stimulation with OKT3 or staurosporine (STS) for the indi-
cated timepoints, in the presence or absence of SM1/23 Ab. (E) Lysates prepared as described in (D) were incubated with the 
caspase 9 specific substrate LEHD-pNA for 2 h, and caspase 9 enzymatic activity was quantitated as OD at 405 nm minus back-
ground (OD405 at 5 min).Biology Direct 2008, 3:34 http://www.biology-direct.com/content/3/1/34
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mitochondrial component, we surveyed expression of
several pro- and anti-apoptotic BCL-2 family members
using microarrays following TCR restimulation of acti-
vated human PBL for 6 h. As a positive control, we
detected significant induction of FASL expression. Nota-
bly, we detected an even greater increase (> 5 fold) in BIM
transcription in response to OKT3 stimulation (Figure
2A). Only BCL-xL was also increased with restimulation,
whereas other BCL-2 family members remained largely
unchanged or slightly decreased. The expression of all
three BIM protein isoforms (extra long (EL), long (L), and
short (S)) also increased substantially over time with
Induction of BIM expression contributes to TCR-induced apoptosis Figure 2
Induction of BIM expression contributes to TCR-induced apoptosis. (A) Mircoarray analysis of designated Bcl-2 family 
members was performed using RNA purified from activated human PBL either untreated (0 h) or stimulated with OKT3 for 6 
h. Relative expression values normalized to reference RNA from normal human PBL are shown at left, fold change following 
TCR restimulation is quantitated at right. (B) Activated human PBL were stimulated with OKT3 for the indicated times, and 
whole cell lysates were prepared and immunoblotted for the proteins indicated on the right. All three isoforms of BIM (extra-
long (EL), long (L), short (S)) were detected. Spot densitometry analysis of the ratio of BIM-EL to BCL-xL (normalized to β-
actin loading control) is plotted below. (C) Activated human PBL were transfected with nonspecific (NS) or Bim-specific 
siRNA, rested 4 days, and then restimulated for 24 h with increasing doses of OKT3 in the presence or absence of SM1/23. 
Percent cell loss was calculated in triplicate by PI exclusion. Differences in apoptosis sensitivity (relative to NS alone) were sta-
tistically significant for each dose of OKT3 (p < 0.04), except for SM1/23 treated NS cells at 1 μg/ml. (D) Lysates from cells 
transfected in (C) were immunoblotted for BIM as in (B). β-actin serves as a loading control. (E) Average extent of TCR-
induced apoptosis inhibition (relative to NS siRNA alone) is shown for each condition described in (D) for 6 different normal 
donor PBL tested.Biology Direct 2008, 3:34 http://www.biology-direct.com/content/3/1/34
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OKT3 restimulation, whether Fas blockade was applied or
not (Figure 2B). Although BCL-xL protein levels also
increased, the ratio of BIM:BCL-xL expression rose sub-
stantially over time, suggesting heightened Bim expres-
sion represents a "tipping point" for overcoming the anti-
apoptotic function of BCL-xL and related proteins in driv-
ing mitochondrial depolarization. PUMAβ levels also
showed a minor increase (Figure 2B). Remarkably, the
quick induction of BIM upon restimulation occurred in
the presence of IL-2, which is required for TCR-induced
death[6]. IL-2 signaling alone can destabilize BIM mRNA
or promotes BIM protein degradation via Raf/ERK or
phosphoinositide kinase 3 (PI-3K) signaling pathways
[25-27]. However, our results suggest the TCR restimula-
tion overrides this signal to allow for rapid BIM upregula-
tion. These data are consistent with previous observations
indicating BIM expression can be induced upon TCR trig-
gering in human CTL clones, depending on the agonistic
peptide used [28,29]. However, these studies did not
establish whether loss of BIM expression had functional
consequences for TCR-induced apoptosis sensitivity, or
how this related to FAS-FASL signaling.
To definitively test whether BIM contributes to the TCR-
induced apoptosis signal, we silenced BIM expression by
RNA interference (RNAi) in activated PBL and restimu-
lated them with OKT3 with or without FAS blockade.
Knockdown of BIM expression significantly reduced the
sensitivity of activated PBL to TCR-induced death (Figure
2C). Control immunoblots showed that BIM expression
was silenced effectively in cells that received BIM-specific
siRNA both before and after restimulation (Figure 2D,
Additional File 2). As noted above, FAS blockade also par-
tially rescued cells from death in these experiments, and
had an additive protective effect when BIM expression was
reduced (Figure 2C). The protective effects of BIM sup-
pression and Fas blockade were noted in multiple human
donors (Figure 2E). Knockdown of FAS associated death
domain (FADD) rescued cells from TCR-induced death to
a similar extent, further illustrating that death receptor sig-
naling is only part of the apoptotic signal triggered by TCR
restimulation (Additional File 3). In addition, knock-
down of PUMA also provided some protection from TCR-
induced death (Additional File 4), although this effect was
variable in different donors tested. Collectively, our data
definitively shows that intrinsic apoptosis mediators, par-
ticularly BIM, are required for optimal apoptosis triggered
by TCR re-engagement separate from extrinsic FAS-
induced apoptotic signals.
Relative contribution of BIM in CD4+ versus CD8+ TCR-
induced death
We next tested whether BIM induction played a role in
TCR-induced death of both CD4+ and CD8+ T cells. Puri-
fied CD4+ and CD8+ T cells sorted from activated PBL were
transfected with NS or BIM-specific siRNA and tested for
sensitivity to OKT3-induced death. Whereas Fas blockade
alone substantially rescued the apoptosis of purified
CD4+ T cells, knockdown of Bim expression had little
effect (Figure 3A). Conversely, CD8+ T cells relied on both
FAS and BIM for TCR-induced apoptosis signaling.
Although BIM expression was consistently higher in CD4+
Bim is important for TCR-induced apoptosis of CD8+ T cells Figure 3
Bim is important for TCR-induced apoptosis of CD8+ T cells. (A) CD4+ or CD8+ T cells purified from activated human 
PBL were transfected with NS or Bim-specific siRNA, rested 4 days, then restimulated with increasing doses of OKT3 in the 
presence or absence of SM1/23. Percent cell loss was calculated in triplicate by PI exclusion. Differences in apoptosis sensitivity 
were statistically significant for SM1/23 treated CD4+ cells (NS and Bim) compared to NS cells alone (p < 0.007), except for 
SM1/23 treated NS cells at 1 μg/ml OKT3 (p < 0.07). Differences in apoptosis sensitivity for CD8+ T cells (relative to NS alone) 
were all statistically significant (p < 0.05). (B) Lysates from cells transfected in (A) were immunoblotted for BIM. β-actin serves 
as a loading control.Biology Direct 2008, 3:34 http://www.biology-direct.com/content/3/1/34
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T cells compared to CD8+ T cells from multiple donors
(Figure 3B), BIM induction from steady state levels was as
good or better in CD8+ T cells upon restimulation (Addi-
tional Files 2 &5). We cannot rule out that residual BIM
expression in CD4+ T cells following BIM siRNA transfec-
tion contributed to the Fas-independent of apoptosis
observed. However, other experiments revealed that BIM
knockdown using the same siRNA provided greater pro-
tection from IL-2 withdrawal apoptosis in CD4+ T cells
(Additional File 6), suggesting BIM levels could be suffi-
ciently depleted to hinder BIM-dependent death. Collec-
tively, the data suggests that human CD8+ T cells rely on
BIM more extensively for TCR-induced deletion than
CD4+ T cells, which are largely dependent on FAS signal-
ing. This idea agrees with landmark studies that impli-
cated FAS in TCR-induced apoptosis, which focused
primarily on CD4+ T cell lines or clones from humans or
mice [15-18]. Moreover, our data potentially explain new
studies suggesting BIM drives Ag-specific CD8+ T cell dele-
tion in establishing peripheral tolerance in both mice and
humans [30,31].
Bim and Fas cooperate in TCR-induced apoptosis of 
murine T cells
In light of our findings in human T cells, we re-examined
TCR-induced death in murine T cells. Surprisingly, we
observed that activated splenic T cells from Fas-deficient
lpr  mice showed only minor resistance to anti-CD3-
induced death induced by restimulation, whereas bim
knockout mice showed no difference in sensitivity com-
pared to WT cells (Figure 4A). We also tested for Bim
induction in restimulated WT and lpr T cells in the pres-
ence of IL-2. Consistent with data in human T cells, acti-
vated mouse T cells (WT or lpr) showed a clear increase in
BimEL expression after 6 hours of restimulation (Figure
4B). We also detected a change in the migration of BimEL
and BimL isoforms, suggesting post-translational modifi-
cations may affect of bim function in mice, perhaps via
phosphorylation.
Next, we reasoned that differences in apoptosis sensitivity
caused by loss of Fas or Bim may differ in CD4+ and CD8+
T cell cultures, as noted in for human T cells. Therefore, we
assayed TCR-induced apoptosis sensitivity in purified
CD4+ and CD8+ T cells from WT, lpr, and bim-/- mice. As
expected from previous reports, CD4+ lpr cells showed a
profound defect in restimulation-induced death (Figure
4C). This concurred with our results in human CD4+ T
cells using Fas blocking Ab (Figure 3A), indicating Fas is
necessary for CD4+ T cell restimulation apoptosis. In con-
trast, there were no differences in CD8+  T cell death
between restimulated WT and lpr  cells, explaining the
cumulatively minor rescue of TCR-induced death in total
splenic T cells when Fas is absent. Furthermore, genetic
ablation of bim had little protective effect for activated
CD4+ T cells upon TCR restimulation, and no discernible
effect on apoptosis in CD8+ T cells (Figure 4D).
We hypothesized that loss of Bim from development,
through germline gene ablation, may permit T cells to
"compensate" accordingly via enhanced expression or
function of pro-apoptotic molecules. Therefore, we
acutely silenced Bim using RNAi in activated WT and lpr T
cells. Knockdown of Bim significantly protected activated
WT and lpr T cells from apoptosis induced by 100 ng/ml
anti-CD3 stimulation (Figure 4E, left panel), demonstrat-
ing that Bim can play a prominent role in this apoptosis
pathway. This effect was also noted in purified CD4+ and
CD8+ T cell populations (data not shown), even though
loss of Fas alone reduced sensitivity only in CD4+ T cells
again as expected. Control blots showed that Bim siRNA
effectively suppressed Bim protein expression in both WT
and lpr T cells (Figure 4E, right panel). This protective
effect was less pronounced at higher doses of anti-CD3
stimulation (data not shown), suggesting stronger restim-
ulation may override Bim siRNA effects and/or trigger
alternative death effector pathways. Thus, our data sug-
gests that Fas or Bim may partially compensate for the loss
of one or the other from development in murine T cells
during development.
Relative BIM expression correlates with sensitivity to TCR-
induced death in ALPS patients
Based on our aforementioned results, we revisited TCR
restimulation-induced apoptosis in PBL derived from sev-
eral ALPS patients. Similar to controls, PBL cultures from
ALPS Ia patients were primarily comprised of CD8+ T cells
(data not shown). Surprisingly, we found that PBL from
several ALPS Ia patients displayed normal or slightly more
death in response to OKT3 titration compared to normal
controls, despite impaired apoptosis upon direct Fas
crosslinking. (Figure 5A, Additional File 7). Similarly, T
cells derived from an ALPS Ib patient harboring a domi-
nant interfering mutation in FASL [32] were also killed
effectively upon TCR restimulation (Figure 5B). Consist-
ent with defective FASL function, TCR-induced apoptosis
was unaffected by Fas blockade. These results exposed a
glaring contradiction in the concept that FAS mediates
most or all TCR-induced death.
We next assessed the relative expression of BIM before and
after restimulation of PBL in ALPS Ia patients. In general,
we noted higher BIM protein expression in restimulated
ALPS Ia T cells relative to controls (Figure 5C). In 4/6 ALPS
Ia patients, steady-state BIM expression was also elevated
relative to controls. Using spot densitometry, we esti-
mated that ALPS Ia T cells had between 30–80% more
BIM protein than normal controls both before and after
TCR ligation (Figure 5C, bottom panel). BIM siRNA treat-
ment did not result in a significantly greater rescue ofBiology Direct 2008, 3:34 http://www.biology-direct.com/content/3/1/34
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TCR-induced death in ALPS Ia cells compared to normal
controls (data not shown), perhaps due to incomplete
depletion of BIM or compensation by other mediators
(e.g. PUMA). Nevertheless, elevated BIM levels in cycling
T cells with defective FAS function may suggest that these
T cells are "primed" for apoptotic deletion through a com-
pensatory increase in BIM expression.
Finally, we tested TCR-induced apoptosis in T cells
derived from an ALPS Type IV patient (P58) with a gain-
of-function, germline NRAS mutation that constitutively
activates ERK and suppresses BIM expression. We recently
demonstrated that P58 T cells are resistant to apoptosis
induced by IL-2 withdrawal due to BIM suppression[12].
Remarkably, P58 T cells displayed partial resistance to
Fas and Bim cooperate in driving TCR-induced apoptosis of murine T cells Figure 4
Fas and Bim cooperate in driving TCR-induced apoptosis of murine T cells. (A) Activated splenic T cells from wild-
type (WT), lpr, or bim-/- mice were restimulated with platebound anti-CD3 for 24 h. Percent cell loss was calculated in triplicate 
by PI exclusion. (B) Lysates from splenic T cells from the indicated genetic backgrounds left untreated or restimulated with 
platebound anti-CD3 for 6 h were immunoblotted for Bim isoform expression. β-actin serves as a loading control; asterisk 
indicates non-specific band. (C, D) CD4+ and CD8+ T cells were purified from activated WT, lpr, or bim-/- splenocytes and res-
timulated with platebound anti-CD3 for 24 h. Percent cell loss was calculated in triplicate by PI exclusion. (E) Splenic T cells 
from WT or lpr mice were stimulated for 48 h with platebound anti-CD3/anti-CD28, washed, and transfected with NS or Bim-
specific siRNA. Three days post-transfection, cells were restimulated with 100 ng/ml platebound anti-CD3; percent cell loss 
was calculated in triplicate by PI exclusion. Differences in apoptosis sensitivity (relative to NS-treated WT cells) were statisti-
cally significant (p < 0.04). Lysates made from cells three days post-transfection were assessed for Bim knockdown by immuno-
blotting, right.Biology Direct 2008, 3:34 http://www.biology-direct.com/content/3/1/34
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TCR-induced death when compared to normal donor and
ALPS Ia cells, despite comparable expression of FAS on the
cell surface (Figure 5D, Additional File 8). Moreover, BIM
expression was attenuated in P58 T cells and could not be
rescued by TCR restimulation (Figure 5E), providing
stronger evidence that BIM serves a physiologically rele-
vant role in the restimulation apoptosis pathway, espe-
cially for CD8+ T cell homeostasis. Moreover, our data
implies that relative BIM expression may represent an
important determinant of TCR-induced apoptosis sensi-
Suppression of Bim expression in ALPS type IV patient causes resistance to TCR-induced death Figure 5
Suppression of Bim expression in ALPS type IV patient causes resistance to TCR-induced death. (A) Activated 
human PBL from normal control donors (NC1, NC2), or 6 ALPS type Ia patients were restimulated with increasing doses of 
OKT3 for 24 h. Percent cell loss was calculated in triplicate by PI exclusion. (B) Activated human PBL from an ALPS type Ib 
patient or a normal control donor (NC) were treated as in (A). Percent cell loss was calculated in triplicate by PI exclusion. (C) 
Activated human PBL from normal control donors (NC1, NC2), or 6 ALPS type Ia patients restimulated with 100 ng/ml OKT3 
for 0 (-) or 8 h (+), lysed and immunoblotted for BIM. β-actin serves as a loading control. Spot densitometry analysis of the 
ratio of BIM (EL isoform) to β-actin (normalized to NC1 untreated, dashed line) is plotted below. (D) Activated human PBL 
from normal control donors (NC1, NC2), an ALPS type Ia patient, and an ALPS Type IV patient (P58) were restimulated with 
OKT3 for 24 h. Percent cell loss was calculated in triplicate by PI exclusion. Differences in apoptosis sensitivity (relative to 
NC1 or NC2) were statistically significant (p < 0.01). (E) Activated human PBL as in (D) were restimulated with 100 ng/ml 
OKT3 for 0 (-) or 8 h (+), lysed and immunoblotted for BIM. β-actin serves as a loading control.Biology Direct 2008, 3:34 http://www.biology-direct.com/content/3/1/34
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tivity, independently of FAS. However, we concede that
NRAS/ERK dysregulation in P58 could alter TCR-induced
death through BIM-independent mechanisms as well.
Indeed, pharmacological ERK inhibitors actually pro-
vided a small but reproducible rescue of TCR-induced
death in both normal and P58 T cells.
The physiological function of Bim was originally revealed
from characterization of Bim-deficient mice, from which
T cells were profoundly resistant to lymphokine with-
drawal death[8]. The pro-apoptotic function of Bim also
enforces immune tolerance through thymocyte negative
selection, CD8+ T cell cross tolerance, and the regulation
of antigen presenting cells including B cells and dendritic
cells[23,33-35]. Here we demonstrate that BIM also plays
a significant role in TCR-induced death of activated
human T cells, working in tandem with FAS signaling as a
separate signal to kill T cells. This provides a new mecha-
nism besides the cleavage of BID for an extrinsic signal to
activate the intrinsic mitochondrial death program. This
paradigm may be distinct from Bim-dependent "activated
T cell death" described by Hildeman et al. in mice chal-
lenged with a single dose of superantigen [36], which may
be interpreted as predominantly cytokine withdrawal
apoptosis, not restimulation-induced death with repeated
Ag dosing. On the other hand, the marked accumulation
and persistence of Bim-deficient murine CD8+ T cells in
chronic viral infection models could be connected to
failed deletion in response to repeated TCR stimulation
[37,38].
Our results show that direct signals from the TCR program
T cells to die through Bim, which is fundamentally differ-
ent from the secretion of death cytokines such as FasL that
engage external death receptors. This has some interesting
implications. First, it may be advantageous in conditions
where Fas may not be effective. For example, Bim has a
greater influence in CD8+ T cells that can utilize FasL:Fas
as a calcium-independent cytolytic mechanism against
infected target cells and therefore may be inured to its
lethal effects. Second, the direct molecular connection
inside the cell may make the Bim pathway more efficient.
Careful investigation of the temporal effects of killing
after TCR engagement may reveal differences between Fas
and Bim effectiveness. Third, as Bim expression is exten-
sively regulated post-translationally, the fact that transla-
tion inhibitors only partially block TCR-induced death
could indicate there is a direct death pathway entrained to
TCR restimulation that does not require new protein syn-
thesis [17]. Finally, pro-apoptotic mediators like Bim or
Puma acting at the convergence of TCR and CWA may
help to restrain these pathways at a focal point for tight
control of those T cells escape death and emerge as mem-
ory T cells.
Recently, three groups reported that loss of both Bim and
Fas in mice results in massive lymphadenopathy/
splenomegaly, early onset of SLE-like autoimmune mani-
festations, and even greater accumulation of antigen-spe-
cific CD8+ T cells upon chronic viral infection [39-41].
These experiments reprised earlier work that obtained
very similar results when transgenic Bcl-2 overexpressing
mice were crossed onto an lpr background [42,43]. How-
ever, their general conclusions still emphasized the tradi-
tional model, reiterated in an accompanying review, that
Fas and Bim control T cell homeostasis through two dis-
tinct pathways: restimulation-driven versus IL-2 with-
drawal-induced apoptosis, respectively[5,7,19]. Our study
illustrates that death of activated T cells via Fas or Bim are
not mutually exclusive pathways, as both can operate in
IL-2 dependent TCR-induced apoptosis. During infections
this combination of potent extrinsic and intrinsic signals
may act to ensure rapid and efficient killing of hyper-
responsive or cross-reactive autoimmune T cells upon
repeated antigen encounter, thus preventing immunotox-
icity and maintaining peripheral tolerance. Another
intriguing possibility relates to the potential of Bim and
Fas to partially compensate for one another in driving
TCR-induced apoptosis. This applies to situations where
either gene function is lost from development, such as in
lpr or bim-/- mice, and may explain why only acute knock-
down of Bim resulted in significant reduction of TCR-
induced apoptosis in murine T cells in vitro. The idea that
Bim participates in ensuring T cell homeostasis both dur-
ing and after effector T cell responses may also explain
why Bcl-2 Tg lpr mice described years ago have strikingly
worse lymphocyte accumulation compared to either Bcl-2
Tg or lpr mice alone[43]. Our results provide a new inter-
pretation of the mouse studies by revealing that the infec-
tion-induced derangement of T cell homeostasis caused
by Bim-deficiency could be accounted for by an impair-
ment of both intrinsic and extrinsic apoptosis. It is also
notable that ALPS patients show wide variability in con-
ventional CD3+ T cell numbers, with a substantial fraction
showing no increases. By contrast, the fraction and abso-
lute number of "double negative" (CD4-CD8-) α/β T cells
are invariably elevated [44]. This may reflect that alterna-
tive effectors such as BIM could preserve equipoise in the
conventional T cell compartment.
In humans, our data are consistent with previous studies
suggesting that TCR-induced death involves multiple
effector molecules, and clearly includes components
other than FAS or BIM that remain to be elucidated[22].
We have previously noted a role for tumor necrosis factor-
alpha (TNF-α) in this process for murine CD8+ T cells[21];
however, blockade of this pathway in human T cells had
little demonstrable effect (data not shown), which
requires further exploration. A recent paper from Mateo et
al. implicated perforin and cytotoxic granules in the exe-Biology Direct 2008, 3:34 http://www.biology-direct.com/content/3/1/34
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cution of TCR-induced death, particularly for ALPS Ia
patient cells[45]. Other inputs implicated in control of
AICD sensitivity, including NF-κB regulation through
HPK-1 or generation of reactive oxygen species (ROS),
likely relate more to the regulation of FasL or Bim expres-
sion[46,47]. However, we are studying patients with
impaired TCR-induced apoptosis despite normal induc-
tion of FASL and BIM, and normal apoptosis triggered by
FAS ligation or IL-2 deprivation (A.L. Snow, unpublished
data). Insights gleaned from such patients may further
advance our understanding of the biochemical complex-
ity and physiological relevance of apoptosis in different
immune cell compartments. Nevertheless, our current
findings further elucidate FAS-independent signals for the
restimulation-induced death of activated T cells via BIM
induction.
Conclusion
Although Fas-FasL signaling is often considered synony-
mous with TCR restimulation-induced death, the data
provided herein show it has a quantitatively lesser role
than previously acknowledged, and support a critical role
for BIM induction in the execution of antigen-driven
"extrinsic" apoptosis. Increased BIM expression following
TCR restimulation, even with a surfeit of IL-2, works in
parallel to FAS signaling in driving mitochondrial depo-
larization, caspase 9 activation, and eventual apoptosis.
Like FAS blockade, suppression of BIM induction via
RNAi or increased NRAS activity in an ALPS variant
patient results in partial resistance to TCR-induced death.
These data build upon previous work from Sandalova and
colleagues by demonstrating that BIM is indispensable for
maximum sensitivity to restimulation-induced apoptosis
of human T cells. More importantly, our findings revise
previous models in showing that FAS and BIM both par-
ticipate in eliminating activated T cells through this IL-2
dependent, propriocidal death pathway.
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Fas ligand; PBL: Peripheral blood lymphocytes; PI: Pro-
pidium iodide.
Competing interests
The authors declare that they have no competing interests.
Authors' contributions
ALS and JBO designed and performed all experiments.
ALS wrote the manuscript. LZ helped with activation and
analysis of ALPS Type Ib cells. JKD. cared for ALPS patients
and facilitated sample collection and distribution. MJL
and TAF helped direct the research and contributed to
final revisions.
Reviewers' comments
Reviewer #1, Snow et al.:
Dr. Wendy Davidson, University of Maryland School of
Medicine
Editor: Dr. David Scott, University of Maryland School of
Medicine
This manuscript examines the role of BIM in TCR restim-
ulation-induced death in human T cells from healthy
individuals and patients with ALPS. The authors show
that restimulation of normal unfractionated T cell blasts
results in significant upregulation of BIM expression and
that reactivation-induced cell death (AICD) is reduced
when FAS/FASL interactions are blocked with antagonist
Ab or BIM expression is decreased by siRNA. Blockade of
both pathways appeared to have additive effects suggest-
ing that both BIM- and FAS-mediated death pathways
contribute to AICD. Further analysis of T cell subsets
showed that although CD4+ T cell blasts express higher
levels of BIM than CD8+ T cell blasts prior to and after res-
timulation, BIM-mediated death appears to be restricted
to CD8+ T cells. Combined, the data on subsets suggest
that AICD in CD4+ T cells is predominantly FAS-mediated
whereas CD8+ T cells are susceptible to death induced by
FAS and BIM. Additional studies with unfractionated T
cell blasts from ALPS patients deficient in FAS or FASL
indicated sensitivity to FAS-independent AICD, increased
basal levels of BIM and increased expression of BIM post
restimulation. However, attempts to block AICD using
BIM siRNA were unsuccessful. As an alternative indirect
approach to determine the contribution of BIM to AICD
in the context of ALPS, the investigators used T cells from
an ALPS type IV patient with a germline NRAS mutation
resulting in constitutive activation of ERK and suppres-
sion of BIM expression. Unfractionated T cell blasts from
this patient were efficiently killed by anti-FAS mAb but
were relatively insensitive to TCR-induced death, suggest-
ing that BIM might contribute to AICD.
The findings with normal human CD8+ T cells are novel
and consistent with recent studies in mice indicating the
importance of both the BIM and FAS cell death pathways
in regulating CD8+ T cell homeostasis. The data relating to
the role of BIM in T cell death in ALPS patients are less
compelling because of the difficulties in efficiently down-
regulating BIM in T cell blasts from ALPS type I patients.
Further, in the ALPS type IV patient the authors assume,
but do not prove, that the only way that dysregulated
expression of NRAS protects T cells from restimulation-
induced death is through down regulation of BIM.
Critique:Biology Direct 2008, 3:34 http://www.biology-direct.com/content/3/1/34
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Major points:
1. The key data shown in Figs. 2C and 3A appear to be
from a single experiment utilizing cells from one individ-
ual. The investigators should indicate how reproducible
the studies were and whether there was significant varia-
tion in susceptibility to BIM-mediated killing among T
cells from different individuals.
Author Response
The reviewer poses an important question. Although some var-
iation was noted in cells from different donors, the experiments
described were very reproducible in multiple replicate experi-
ments, utilizing several human donors. In order to clarify this
point, Figure 2E has been added to summarize the extent of
TCR-induced apoptosis inhibition, relative to NS siRNA-trans-
fected cells, for 6 different human donors tested.
2. In Fig. 2D, the authors show that BIM expression is sig-
nificantly reduced in T cell blasts after transfection with
BIM siRNA. The authors do not specify whether the cell
lysates came from blasts 4 days post transfection or from
restimulated transfected blasts. Similar data shown in
Additional File 2 indicate that western blots were per-
formed prior to restimulation. It is imperative that the
authors demonstrate that restimulation-induced upregu-
lation of BIM is prevented in the BIM siRNA transfected
blasts. Otherwise, the data cannot be interpreted.
Author Response
We agree with the reviewer's critique, as blots shown represent
cells lysed 4 days post-transfection of siRNA without restimula-
tion. To address this point, the new Additional File 2 now dem-
onstrates that Bim siRNA effectively suppresses BIM expression/
induction in both resting and restimulated T cells.
3. Data in Fig. 3A suggest that BIM either does not contrib-
ute to restimulation-induced death in CD4+ T cell blasts or
that the BIM death pathway is far less efficient than the
FAS death pathway in inducing apoptosis in this popula-
tion. Studies with Bim KO mice may help to distinguish
between these two possibilities, assuming that murine
CD4+ T cells reliably model human CD4+ T cells in this
regard. Decreased sensitivity of BIM knockdown CD4+
blasts to IL-2 withdrawal-induced death would provide
additional evidence that BIM levels are sufficiently
depleted to impair BIM-dependent death.
Author Response
Following the reviewer's suggestion, we have added a new fig-
ure detailing several experiments performed with mouse T cells
from Bim KO as well as lpr mice (new Figure 4). These data
support the conclusion that CD4+ T cells are much less depend-
ent on Bim compared to Fas for TCR-induced death, although
we found that CD8+ T cells were equally sensitive to the block-
ade of either pathway. On the other hand, acute knockdown of
Bim expression in mouse T cells rescued a substantial propor-
tion of WT T cells, and almost all lpr T cells, from TCR-induced
apoptosis. We hypothesize that Bim KO cells maintain sensitiv-
ity to TCR-induced death through a compensatory effector mol-
ecule (Fas or otherwise), such that the acute knockdown in WT
cells does not allow sufficient time or the physiological context
for a hypothetical compensatory mechanism to have a signifi-
cant effect.
We also provide new data (Additional File 6) showing that our
RNAi approach provides sufficient depletion of BIM to impair
BIM-dependent, IL-2 withdrawal apoptosis in CD4+ T cells. In
fact, the extent of this protection was more pronounced for
CD4+ T cells compared to CD8+ T cells. This contrast suggests
the more prominent role of BIM in human CD8+ T cell dele-
tion, supported by our data in Figure 3, is specific to TCR res-
timulation-induced death.
In Fig. 2C, the data suggest that the FAS and BIM death
pathways are equally effective in killing blasts enriched for
CD8+  cells. However, in Fig. 3A purified CD8+  blasts
appear to be more sensitive to FAS-mediated death. This
difference deserves comment. The author's should also
indicate whether the greater sensitivity of CD8+ blasts to
FAS-mediated death is a consistent finding in healthy
humans. As discussed above for the unfractionated blast
populations, data showing that siRNA blocks the restimu-
lation-induced increase in BIM expression in the purified
CD4+ and CD8+ are essential.
Author Response
In general, we cannot definitively say that purified CD8+ T cells
are more sensitive to the Fas-FasL component of TCR-induced
death than unfractionated PBL. The data shown in Figure 3A
are representative of several experiments, although some varia-
bility in the extent of rescue by the Fas antagonist antibody
SM1/23 was noted in both purified CD8+ T cells and PBL. As
noted in the text, the majority of T cells found in normal donor
PBL (roughly 55–80%) were CD8+ T cells following a week of
cycling in IL-2. As mentioned above, Additional File 2 demon-
strates that Bim-specific siRNA blocks the restimulation-
induced increase in BIM expression in purified T cell subsets.
4. Although T cells from ALPS patients with defects in FAS
signaling are clearly susceptible to AICD and exhibit
increased expression of BIM after restimulation, no con-
clusions can be drawn regarding the contribution of BIM
in FAS-independent apoptosis in CD4+ or CD8+ T cells
since the authors were unable to block BIM expression.
While the ALPS type IV patient, P58, with reduced BIM
levels and decreased sensitivity to AICD provides addi-
tional preliminary evidence for a role for BIM in T cell
homeostasis, the authors should address the possibility
that the enhanced cell survival associated with NRAS dys-Biology Direct 2008, 3:34 http://www.biology-direct.com/content/3/1/34
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regulation may result from effects other than, or in addi-
tion to, BIM downregulation.
In Fig. 4D, the investigators show that P58 blasts are
highly sensitive to anti-FAS-induced apoptosis but do not
establish whether FAS-mediated AICD is intact. Ideally,
the AICD experiments should be repeated with isolated
P58 CD4+ and CD8+ blasts in the presence or absence of
antagonist anti-FAS Ab to determine the level of FAS-
mediated apoptosis in each population. If P58 CD4+
blasts are sensitive to AICD and death is significantly
inhibited by FAS blockade, the investigators will have
additional evidence that BIM contributes minimally to
AICD in CD4+ T cells.
Author Response
We appreciate the authors' interpretation. Accordingly, we now
provide additional commentary in the Discussion to point out
that the gain-of-function NRAS mutation in P58 T cells could
be altering TCR-induced death signaling through additional
unidentified BIM-independent pathways. Although purified
CD4+ and CD8+ T cells were not tested, TCR-induced death in
P58 PBL could be partially rescued by Fas blockade to a similar
extent as normal donor T cells, suggesting FasL function is
intact. We also concur that enhanced BIM expression in ALPS
Ia patients is suggestive, but not definitive, evidence for BIM-
dependent AICD short of better knockdown experiments.
Minor Points:
1. In their discussion (page 14, line 10), the authors over-
state the differences between their interpretation of how
FAS and BIM may work to regulate T cell homeostasis and
the conclusions of three other groups studying mice defi-
cient in Bim and functional Fas.
Authors Response
We respectfully disagree with the author's opinion in this case,
as we feel it is imperative to highlight the novelty of our findings
in relation to the three cited articles pertaining to Bim-deficient
lpr mice. The "preview" article published alongside those arti-
cles in Immunity (see references in the manuscript) maintains
that Fas controls antigen-stimulated or "active" death, and
cytokine withdrawal death governed by Bim and its interactions
with other Bcl-2 family members controls antigen depletion or
"passive" death in a mutually exclusive manner. Actually our
data indicate that both of these contentions are oversimplified.
Ample data indicates that Fas is not the only mediator of TCR-
stimulated death of activated cells illustrated in all of the exper-
iments in this paper by the fact that substantial residual death
evident even with combined Fas/Bim blockade. Moreover, our
data demonstrate that Fas and Bim can both contribute to
apoptosis caused by TCR restimulation of activated T cells. This
provides a different molecular schema for interpreting the syn-
ergistic increase in lymphadenopathy and autoimmunity they
reported resulting from combined genetic lesions of Fas and
Bim. It is clear from those papers and the overview written by
Green that the interpretation is confined to a model that has
existed in the field for over a decade, viz Lenardo, J. Exp. Med.
183: 1071, 1996. Our new findings reveal a functional con-
nection between the TCR-induced pathway and Bim that was
previously hinted at in the literature (Sandalova et al., Hum
Immunol. 2006 Dec;67(12):958–65) and not considered in
the 2008 Immunity papers. This sheds new light on the
described phenotype of these mouse experiments, particularly
with regard to excessive CD8+ T cell lymphoproliferation, that
was not considered.
2. Since the difference in susceptibility of CD4+ and CD8+
T cells to BIM-mediated AICD is a novel observation, the
authors should discuss this data more extensively.
3. Information on the source of the SM1/23 mAb and a
reference for the cell death assay need to be included in
the Methods section.
4. In Fig. 4B, the axis label for OKT3 concentration should
read μg/ml. On page 7 there is are typos in the spelling of
microarray. Data is plural.
Author Response
We have elaborated on our discussion of differences in BIM-
driven TCR-induced death of CD4+ and CD8+ T cells as recom-
mended by the reviewer. We have also added two very recent
references that demonstrate a prominent role for BIM in Ag-
specific peripheral deletion of CD8+  T cells in mice and
humans, in agreement with our in vitro data. The information
requested is now provided in the text, and typos have been cor-
rected.
Reviewer #2, Snow et al.:
Dr. Mark Williams, University of Maryland School of
Medicine
Editor: Dr. Neil Greenspan, Case Western Reserve Uni-
versity
Recent papers suggest that the role of Bim in classic TCR-
induced AICD is not well defined. This paper addresses
this question.
The data in Figure 2 suggest that Bim plays a role in AICD
in the T cells from normal controls, but the data from the
ALPS patients in Figure 4 do not allow such an interpreta-
tion. The P58 cells could be resistant to AICD for many
other reasons besides a lack of Bim. For example FasL lev-
els are not examined or TCR signals needed to sensitize to
AICD may be deficient. The Bim siRNA data in ALPS
patients also should be shown (page 13).Biology Direct 2008, 3:34 http://www.biology-direct.com/content/3/1/34
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Authors Response
We concede that because we were unable to knockdown BIM
expression adequately in ALPS Ia patient cells, data shown in
Figure 5C do not conclusively show that BIM plays a more
prominent role in TCR-induced death of ALPS Ia patient cells.
However, elevated BIM expression noted in several ALPS Ia
patients strongly suggests that other apoptosis effector mole-
cules, including BIM, may be compensating for the loss of func-
tional Fas in maintaining sensitivity to TCR-induced death.
The striking sensitivity of ALPS cells to TCR-induced death is a
surprising effect that we believe has been unequivocally demon-
strated. Indeed, a similar interpretation may be derived from
our new data in Bim KO and lpr T cells (see new Figure 4).
Please note our response to Reviewer 1 with regard to interpret-
ing data from P58 cells.
Statistical analysis is needed for all graphs (the word "sig-
nificantly" is used throughout the text) especially in Fig-
ure 3 to establish that Bim knockdown gives additional
protection above Fas blockade.
Authors Response
We point out that statistical analysis (paired T tests) was
applied to all of the graphs shown throughout the paper, as
noted in the Figure Legends (p values are included). This sta-
tistical analysis is now mentioned in the Methods section for
clarification. The word "significantly" was applied in the man-
uscript with these statistical analyses in mind, referring only to
differences with p < 0.05.
Overall, the data support a role for Bim in AICD, albeit
not as strongly as the authors suggest. More studies in
which Bim expression is manipulated are necessary to
support such a conclusion.
Authors Response
Currently, direct silencing of BIM using siRNA is our most
effective tool for manipulating BIM expression in primary
human T cells. Unfortunately, ectopic expression of BIM in pri-
mary cells is more problematic, as cell viability is poor due to
both BIM overexpression and increased cell loss during electro-
poration of an expression plasmid. We hope that the inclusion
of new data in Figure 2E and Additional File 2 strengthens our
conclusion that BIM siRNA effectively suppresses BIM expres-
sion during restimulation, translating to AICD resistance in
multiple human donors tested. Furthermore, the effect of acute
Bim knockdown in WT and lpr mouse T cells resembles our
data in human T cells and supports our general hypothesis fur-
ther.
Reviewer #3, Snow et al.:
Editor: Laurence C. Eisenlohr, Thomas Jefferson Uni-
versity
Comments:
1. In reference to the term "propriocidal cell death": I'm
familiar with "proprioception" but not "propriocidal".
Author Response
We employ the term "propriocidal", based on the Latin prefix
("proprio" = "of his own accord"), to refer to TCR-induced
apoptosis as a self-regulatory form of T cell death. This has been
introduced in the literature on this topic in the past: Nature
353: 858–861, 1991, Eur. J. Immunol., 23: 1552–1560,
1993. Although this term may be somewhat recondite, it is
interesting that the Editor draws the intended analogy. Just as
the proprioceptive system of inhibitory neurons provides nega-
tive feedback to control motor movements, we theorize that the
negative feedback of propriocidal T cell death can govern the
intensity of an immune response to prevailing conditions of
antigen and IL-2. To avoid confusion we will clarify this term
in the Introduction and Discussion.
2. In reference to first sentence of "Conclusions" section
of Abstract: This sentence is a speed bump for me. This is
the first mention of IL-2 but the implication is that you see
BIM upregulation under both conditions – restimulation
and IL-2 withdrawal. Is the IL-2/BIM connection already
published?
Author Response
As explained in the Introduction, the connection between IL-2
withdrawal and BIM upregulation is well established in the lit-
erature. However, we emphasize our novel finding that robust
BIM upregulation in the presence of IL-2 upon TCR restimula-
tion suggests a different signal emanating from the TCR can
override BIM destabilization normally conferred by IL-2R sign-
aling.
3. In reference to Introduction (pg 4, paragraph 2): This
sentence seems a little off point. If I understand correctly,
it is illustrating how Fas might play a role beyond T cells
in controlling autoimmunity, not how TCR-induced
death can be mediated via a non-Fas mechanism.
Author Response
We agree with the reviewer's opinion, and have modified the
sentence in question to emphasize that these data suggest Fas is
less important for killing activated T cells in the context of
repeated antigen restimulation than previously presumed. The
next sentence provides further detail on this point.
4. You need to confirm that the SM1/23 antibody is satu-
rating. Have you tried a dose-response where it flattens
below 100%? Does this adequately address the issue of
saturating antibody, as PBL were used in both cases.Biology Direct 2008, 3:34 http://www.biology-direct.com/content/3/1/34
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Author Response
We have confirmed that use of SM1/23 Fas blocking Ab is sat-
urating at the 1 μg/ml dose used throughout the study, both in
primary human T cells as well as Jurkat T cell lines. Adding
more than 1 μg/ml did not provide additional protection.
5. In reference to sentence on pg 10 ("IL-2 signaling nor-
mally destabilizes BIM mRNA or promotes BIM protein
degradation via Raf/ERK or phosphoinositide kinase 3
(PI-3K) signaling pathways.") Is this the right word or
would "alone" be better?
Author Response
Per the reviewer's suggestion, we have modified the sentence to
read "IL-2 signaling alone can destabilize BIM mRNA..."
6. In reference to Bim knockdown in CD8+ T cells (Figure
3B, Additional File 3): Could you titrate your siRNA so
that you get a similar level of residual Bim in CD8s and
see if you get the same compromise in apoptosis rescue?
Author Response
We appreciate the reviewer's suggestion, and will try this
approach in subsequent studies. On the other hand, our experi-
ence indicates that adding more siRNA does not improve BIM
knockdown and may lead to off-target effects, which is why we
did not pursue this further in the context of the current study.
7. Insert "T cell" on pg 13 to clarify the term "cross-toler-
ance".
Author Response
The term is added as suggested, thank you.
Additional material
Additional File 1
Blockade of Fas-induced apoptosis in SM1/23 treated PBL. Activated 
PBL were pre-treated with 1 ug/ml SM1/23 Ab prior to addition of 
increasing amounts of APO1.3 Ab. Percent cell loss was calculated 24 h 
later by PI exclusion in triplicate.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1745-
6150-3-34-S1.jpeg]
Additional File 2
Bim siRNA effectively suppresses restimulation-induced BIM expres-
sion in activated T cells. Activated human PBL, purified CD4+ and 
CD8+ T cells were transfected with nonspecific (NS) or Bim-specific 
siRNA and rested for 4 days. Lysates were made from cells left untreated 
(0 h) or restimulated for 8 h with 100 ng/ml OKT3. Knockdown of pro-
tein expression was confirmed by immunoblotting.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1745-
6150-3-34-S2.jpeg]
Additional File 3
Knockdown of FADD or Bim expression results in partial resistance to 
TCR-induced death. Activated human PBL were transfected with non-
specific (NS), FADD-specific, or Bim-specific siRNA, rested for 4 days, 
and then restimulated for 24 h with increasing doses of OKT3 in the pres-
ence or absence of Fas blocking Ab (SM1/23). Percent cell loss was calcu-
lated in triplicate by PI exclusion (left panel). Knockdown of protein 
expression was confirmed by immunoblotting in whole lysates 4 days post-
transfection (right panel).
Click here for file
[http://www.biomedcentral.com/content/supplementary/1745-
6150-3-34-S3.jpeg]
Additional File 4
Knockdown of PUMA results in partial resistance to TCR-induced 
death. Activated human PBL were transfected with nonspecific (NS), 
Puma-specific, or Bim-specific siRNA, rested for 4 days, and then restim-
ulated for 24 h with increasing doses of OKT3 in the presence or absence 
of Fas blocking Ab (SM1/23). Percent cell loss was calculated in triplicate 
by PI exclusion (left panel). Knockdown of protein expression was con-
firmed by immunoblotting in whole lysates 4 days post-transfection (right 
panel).
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Additional File 5
BIM induction in CD4+ vs CD8+ human T cells. CD4+ and CD8+ T cells 
were purified from activated human PBL and restimulated with OKT3 for 
the indicated times. Whole cell lysates were prepared, separated by SDS-
PAGE, and immunoblotted for BIM isoforms or BCL-2 expression. β-actin 
serves as a loading control.
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Additional File 6
BIM siRNA impairs IL-2 withdrawal apoptosis in both CD4+ and 
CD8+ T cells. Purified CD4+ and CD8+ T cells were transfected with non-
specific (NS) or Bim-specific siRNA and rested 24 hrs in IL-2. IL-2 was 
removed by thorough washing, and percent cell loss was calculated 72 and 
96 hrs later by PI exclusion (left panel). The percent of apoptosis inhibi-
tion afforded by BIM siRNA (relative to NS) is graphed in the right panel.
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Additional File 7
Impaired Fas-induced apoptosis in ALPS Ia patients. Activated human 
PBL from normal control donors (NC1, NC2), or 6 ALPS type Ia patients 
were treated with increasing doses of APO1.3 mAb for 24 h. Percent cell 
loss was calculated in triplicate by PI exclusion.
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